Company: RGBP
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001641172-25-022884
Chunk: 22

Company: Regen BioPharma Inc
Filing Date: 2025-08-11
Form: 10-Q
Item: Part I, Item 2
Chunk 22
---
 execute its development plans and continue
operations. Without additional funding, there is substantial doubt about the Company’s ability to continue as a going concern for
the twelve months from the date of these financial statements.

Contractual
Obligations

As
of June 30, 2025 the Company was not party to any binding agreements which would commit Regen to any material capital expenditures.

Off-Balance
Sheet Arrangements

We
did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K promulgated under the Exchange Act.

Item
3. Quantitative and Qualitative Disclosures About Market Risk